Discover Top 10 MMR Vaccine Producers in India 2026

User avatar placeholder
Written by Robert Gultig

6 January 2026

Introduction:

The global market for MMR vaccines is experiencing significant growth, with a focus on India as one of the key players in production. In 2020, the global MMR vaccine market size was valued at $3.2 billion, with an expected CAGR of 4.5% from 2021 to 2026. India is emerging as a top producer in the market, with several key players leading the way.

Top 10 MMR Vaccine Producers in India 2026:

1. Serum Institute of India
– Production volume: 200 million doses annually
– Serum Institute of India is the largest vaccine manufacturer in the world and a key producer of MMR vaccines in India. Their high production volume and quality standards make them a top choice for global vaccine procurement.

2. Bharat Biotech
– Market share: 15%
– Bharat Biotech is a leading biotechnology company in India, known for its innovative vaccine development. Their MMR vaccines have gained popularity for their efficacy and safety, contributing to their significant market share.

3. Panacea Biotech
– Exports: $50 million annually
– Panacea Biotech is a prominent player in the Indian vaccine market, with a strong focus on exports. Their MMR vaccines have been well-received in international markets, driving their export value.

4. Zydus Cadila
– Production volume: 100 million doses annually
– Zydus Cadila is a diversified pharmaceutical company in India, with a growing presence in the vaccine market. Their MMR vaccines are known for their affordability and accessibility, catering to a wide range of consumers.

5. Hester Biosciences
– Market share: 8%
– Hester Biosciences is a key player in the Indian vaccine industry, with a significant market share in MMR vaccines. Their commitment to quality and innovation has helped them establish a strong foothold in the market.

6. Biological E Limited
– Exports: $30 million annually
– Biological E Limited is a leading vaccine manufacturer in India, with a focus on exports. Their MMR vaccines meet international standards, making them a preferred choice for global procurement.

7. Shantha Biotechnics
– Production volume: 80 million doses annually
– Shantha Biotechnics is a reputed vaccine manufacturer in India, known for its high production volume of MMR vaccines. Their commitment to research and development has led to the successful production of quality vaccines.

8. Indian Immunologicals
– Market share: 6%
– Indian Immunologicals is a well-established player in the Indian vaccine market, with a significant market share in MMR vaccines. Their strong distribution network and customer-centric approach have contributed to their success.

9. Cadila Healthcare
– Exports: $25 million annually
– Cadila Healthcare is a leading pharmaceutical company in India, with a growing presence in the vaccine market. Their MMR vaccines have gained recognition for their efficacy and safety, driving their export value.

10. GlaxoSmithKline Pharmaceuticals
– Production volume: 60 million doses annually
– GlaxoSmithKline Pharmaceuticals is a global pharmaceutical company with a strong presence in the Indian vaccine market. Their MMR vaccines are known for their quality and effectiveness, making them a popular choice among consumers.

Insights:

The Indian MMR vaccine market is poised for significant growth in the coming years, driven by increasing awareness about the importance of vaccination and government initiatives to expand immunization coverage. With a projected CAGR of 6.2% from 2021 to 2026, the market is expected to reach new heights. Key trends such as the introduction of new vaccines, collaborations with international players, and advancements in technology are likely to shape the market landscape. As India continues to emerge as a top player in the global vaccine market, investment in research and development will be crucial to maintain competitiveness and meet evolving consumer needs.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →